BMS Medical

medical devices

About

Bristol Myers Squibb (BMS) is a global biopharmaceutical company headquartered in Princeton, New Jersey. The company specializes in the discovery, development, manufacturing, and marketing of innovative prescription medicines and biologics. BMS focuses on serious diseases across various therapeutic areas, including oncology, hematology, immunology, cardiovascular disease, neuroscience, HIV/AIDS, diabetes, hepatitis, and rheumatoid arthritis. BMS operates research and development sites in the US, Europe, and Asia, with manufacturing facilities in several countries. The company reported total revenues of approximately $46.2 billion for fiscal 2022. Its product portfolio includes notable medicines such as Opdivo, Reblozyl, Krazati, Sprycel, and Sotyktu. BMS is committed to advancing health equity and emphasizes responsible business practices and a collaborative culture centered on scientific innovation and patient impact.

Technologies

OutlookMicrosoft Office 365Woo CommerceGoogle Font APIMobile FriendlyWordPress.orgApachereCAPTCHACircleRemoteIoTAI

Keywords

medical equipment manufacturinghealthcare solutionsmedical device regulation compliancemedical device professionalismmedical device regulationmedical device engineering supporticu monitoring systemsmedical device integration servicesmedical device supply chainturnkey healthcare projectshospital equipment logisticsmedical device procurementmedical customer servicehealthcare technology solutionsicu devicesmedical device testinghospital equipment certificationphysiotherapy therapy devicesmedical device softwareicu equipmenthospital infrastructure setupmedical device innovationhospital project turnkey solutionsoperating room equipmentmedical device innovation solutionsmedical device suppliermedical device hardware solutionsmedical device installationhospital equipment maintenancemedical device compliance

Location

Jeddah, Makkah Province, Saudi Arabia

Related Companies

Companies in the same industry